Clinical Trial Site

Montreal, Quebec H4A 3J1

4 studies enrolling now · 9 studies all time

What they study most

Advanced Breast Cancer, Atypical Hemolytic-Uremic Syndrome, Breast Cancer, Chronic Hepatitis B, ER Positive Breast Cancer, Generalized Myasthenia Gravis, HER2 Negative Breast Carcinoma, Hypertension, Iron Deficiency Anemia, Metastatic Breast Cancer, Prostate Cancer Metastatic, Relapsed/Refractory (R/R) Angioimmunoblastic T-cell Lymphoma (AITL)

Studies at this site

• OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer — Recruiting now
• Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs) — Recruiting now
• A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma. — Recruiting now
• Atypical Hemolytic-Uremic Syndrome (aHUS) Registry — Recruiting now
• Trial of ARV-110 and Abiraterone in Participants With Metastatic Prostate Cancer — Completed
• A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension — Completed
• A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM — Stopped early
• A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA) — Completed
• Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B — Stopped early